摘要
分析了1990—2017年美国授权酪氨酸激酶抑制剂类抗肿瘤药物的专利,从申请量、专利权人分布、专利技术领域分布、专利权人演化分析等全面分析酪氨酸激酶抑制剂类抗肿瘤药物在美国的态势,得出一些对我国企业有帮助的竞争情报,为我国相关制药企业提供参考。
The present study analyzed the US granted patents of tyrosine kinase inhibitors from 1990-2017. Our study was systemically analyzed comprehensive information about US granted patents of tyrosine kinase inhibitors including the number of applications, assignee analysis, ICP class analysis, technology evolution of patent assignee. The results will provide very important information and references for the domestic pharmaceutical companies.
出处
《中国发明与专利》
2017年第5期38-41,共4页
China Invention & Patent
